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Does central corneal thickness correlate with haemoglobin A1c
level and disease severity in diabetes type II?
Mehmet Özgür ZENGİN1, Zeynep ÖZBEK2, Gül ARIKAN1, İsmet DURAK3, Ali Osman SAATCİ3

Aim: To compare central corneal thickness (CCT) values of patients with type II diabetes mellitus with those of healthy
subjects, and evaluate the effect of disease duration, retinopathy severity, and HbA1c level on CCT.
Materials and methods: One hundred and twenty-six consecutive type II diabetic patients and 36 non-diabetic healthy
subjects were included in the study. CCT was measured using the Orbscan II corneal topography system. The effect of
disease duration, retinopathy severity, and HbA1c level on CCT was evaluated using analysis of variance (ANOVA) and
the independent sample t test.
Results: CCT was significantly higher in diabetic patients than in non-diabetic subjects. Severity of retinopathy and
disease duration had no apparent effect on CCT. Diabetic patients with HbA1c levels over 7% had thicker corneas than
patients with HbA1c levels under 7% (P = 0.021).
Conclusion: Type II diabetic patients have thicker corneas than non-diabetic subjects. Higher HBA1c level may be a
marker for predicting the increase in CCT in patients with type II diabetes.
Key words: Central corneal thickness, diabetes, disease duration, disease severity

Tip II diabetli hastalarda hastalığın şiddeti ve hemoglobin A1c seviyesi santral
kornea kalınlığı ile ilişkili midir?
Amaç: Bu çalışmada tip II diyabetes mellituslu hastalarda santral kornea kalınlığını (SKK) sağlıklı bireylerle
karşılaştırmak ve hastalık süresinin, retinopati şiddetinin ve HbA1c düzeyinin SKK üzerine etkisini incelemek
amaçlanmıştır.
Yöntem ve gereç: Tip II diyabetli 126 hasta ve diyabeti olmayan sağlıklı 36 olgu çalışmaya dahil edilmiştir. SKK Orbscan
II korneal topografi cihazı ile ölçülmüştür. Hastalığın süresi, retinopati şiddeti ve HbA1c düzeyinin SKK üzerine etkisi
varyans analizi (ANOVA) ve bağımsız değişken t testi ile değerlendirilmiştir.
Bulgular: SKK, tip II diyabetik hastalarda diyabeti olmayanlara göre istatistiksel olarak anlamlı yüksek bulunmuştur.
Retinopati şiddetinin ve hastalık süresinin SKK üzerine belirgin bir etkisi saptanmamıştır. HbA1c düzeyi % 7’nin üzerinde
olan tip II diyabetik hastalarda, HbA1c düzeyi % 7‘nin altında olanlara göre SKK daha fazla saptanmıştır (P = 0,021).
Sonuç: Tip II diyabetli hastalar diyabetik olmayanlara göre daha kalın korneaya sahiptirler. Yüksek HbA1c düzeyi tip II
diyabetli hastalarda artmış SKK için belirleyici bir faktör olabilir.
Anahtar sözcükler: Santral kornea kalınlığı, diyabet, hastalık süresi, hastalık şiddeti
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Introduction
Diabetes mellitus (DM) is a systemic disease that
alters the major metabolic pathway in the human
body and destroys major organ systems. Diabetic
retinopathy is the most common and investigated
ocular complication. However, morphologic and
functional changes in the cornea have been studied
less frequently in diabetic eyes (1-7). Stromal and
subbasal nerve abnormalities (1), low endothelial cell
density and hexagonality (2), reduction in corneal
sensitivity (3), increased corneal autofluorescence (4),
and recurrent corneal erosions (5) are among the
corneal changes observed in diabetic patients.
Corneal thickness has also been evaluated in previous
studies (2,3,6,8,9). However, to the best of our
knowledge, the effects of HbA1c level on central
corneal thickness (CCT) have not so far been studied.
In this prospective study, the CCT of patients with
type II DM was compared with that of healthy
subjects. The correlations of CCT with duration of
diabetes, severity of diabetic retinopathy, and HbA1c
level were analysed.

to diabetes duration (longer or shorter than 10 years)
and HbA1c levels (over or under 7%). The HbA1c
values were obtained within 1 week of the CCT
measurement.
Retinopathy status was evaluated by indirect
ophthalmoscopy following pupillary dilation and
Goldmann 3 mirror examination at the slit-lamp.
Patients were classified according to retinopathy stage.
The first group included 31 patients having diabetes
but no retinopathy, the second group included 30
patients having mild to moderate nonproliferative
retinopathy, the third group included 34 patients
having severe nonproliferative retinopathy, the fourth
group included 31 patients having proliferative
retinopathy, and the fifth group included 36 agematched non-diabetic control subjects. All
measurements were performed at the same time in
the afternoon.
Measurements of the right eye were used for
analysis. Statistical analysis was performed using
analysis of variance (ANOVA) and the independent
sample t test in SPSS version 11.0 (SPSS, Chicago, IL,
USA).

Materials and methods
Our study population comprised 126 consecutive
type II diabetic patients and 36 non-diabetic healthy
subjects. All study subjects underwent a routine
ophthalmologic examination. Patients who had had
previous intraocular surgery, ocular trauma,
intraocular inflammation, and glaucoma, and who
wore contact lenses were excluded. Those who had
received laser photocoagulation within less than 1
month were also excluded. CCT was measured using
the Orbscan II corneal topography system (Bausch &
Lomb, Rochester, NY, USA). Keratometry readings
and refraction values were obtained with an auto
refract-keratometer (Nikon, NRK-8000, Japan) 30
min after the instillation of 1% cyclopentolate
(Sikloplejin, Abdi İbrahim, İstanbul, Turkey) and
0.5% tropicamide (Tropamid, Bilim, İstanbul,
Turkey). Three consecutive measurements were taken
with the Orbscan II and the auto refract-keratometer.
The results of 3 readings were averaged. The steepest
and flattest keratometric values were recorded.
Spherical equivalent was calculated with regard to
refraction. Diabetic patients were classified according
676

Results
Clinical features of the study population are shown
in Table 1. No statistically significant difference was
noted in age distribution among the groups (P =
0.353, ANOVA). Mean duration of diabetes was 12.4
± 7.5 years (range 1-30 years). Central corneal
thickness measurements are shown in Table 1 and the
Figure. The central cornea was significantly thinner
in the control group when compared to all 4 diabetic
groups (P < 0.001, ANOVA) (Table 2). In diabetic
eyes, the central cornea was thicker in eyes in the mild
to moderate nonproliferative retinopathy group when
compared to those in the no retinopathy group (P =
0.034). When diabetic patients were analysed in terms
of disease duration and compared with each other,
CCT was similar in patients that had had diabetes for
less than 10 years and longer than 10 years (P = 0.522)
(Table 3). When the patients were analysed in terms of
HbA1c levels, patients with HbA1c levels over 7% had
thicker corneas than the patients with HbA1c levels
under 7% (Table 4).
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Table 1. Clinical data of the study population.
Control

No
retinopathy

Mild to moderate
nonproliferative
retinopathy

Severe
nonproliferative
retinopathy

Proliferative
retinopathy

36

31

30

34

31

Mean Age (Years)*
(Range)

54.58 ± 8.98
(36-70)

54.35 ± 8.87
(42-77)

56.73 ± 7.95
(42-76)

56.91 ± 9.23
(39-73)

58.03 ± 7.58
(41-72)

Sex (Male/Female)

19/17

15/16

11/19

15/19

12/19

537.11 ± 31.82

555.03 ± 31.49

574.86 ± 39.69

568.29 ± 40.05

556.62 ± 36.70

K (steep axis) (D)

43.09 ± 1.12

43.94 ± 1.64

43.32 ± 3.82

43.57 ± 1.17

43.77 ± 1.45

K (flat axis) (D)

42.77 ± 1.12

43.35 ± 1.5

43.31 ± 1.4

43.11 ± 1.21

43.16 ± 1.5

SE (D)

-0.01 ± 1.15

0.17 ± 1.07

0.29 ± 1.50

0.56 ± 0.90

0.18 ± 1.32

Subjects (n)

CCT (μm)

Centeral Corneal Thickness (μm)

K, mean keratometry reading; D, diopter; SE, mean spherical equivalent
* Mean age of the groups are similar (P = 0.353, ANOVA)

580

Discussion

570

Several studies have evaluated corneal thickness in
diabetic eyes (2,3,6,8-11) (Table 5). Most studies and
the current study showed that diabetic eyes had
increased CCT when compared to non-diabetic eyes
(2,6,8,9). Some studies (3,8,10) included only type I
diabetics and some investigated both type I and II
diabetics (2,6,9,11). Patients with type II diabetics
were studied and it was found that type II diabetics
even without retinopathy had thicker central corneas
than non-diabetic subjects. In contrast to the results
obtained in the present study, Larsson et al. (6) and
Schultz et al. (11) did not find any increase in CCT in
type II diabetics when compared to age-matched
controls.

560
550
540
530
520
510

Control

No retinopathy Mild to moderate
Severe
Proliferative
nonproliferative nonproliferative retinopathy
retinopathy
retinopathy

Retinopathy Severity

Figure 1. Mean corneal thickness values in the study sub-groups
classified according to retinopathy severity.

When mean steep keratometric values in each
subgroup were compared with each other, there was
no statistically significant difference among the
groups (P = 0.469, ANOVA) (Table 1). Mean flat
keratometric values in each subgroup were also
similar (P = 0.423, ANOVA). There was also no
difference among the groups according to spherical
equivalent (P = 0.432, ANOVA) (Table 1).

Why does corneal thickness increase in diabetic
eyes? Although the cause is obscure, it is postulated
that endothelial pump function disturbance due to
reduction of Na+/K+ ATPase activity results in and
increase in stromal hydration (8,9,12). The central
cornea might get thicker following intraocular surgery
even in patients without diabetic retinopathy.
Sometimes corneal oedema may persist following
intraocular surgery in diabetic eyes (13). Therefore,
assessing CCT in diabetic patients before any surgery
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Table 2. Comparative results of CCT among the study groups according to retinopathy severity ¶(P values).
Control

No
retinopathy

Mild to moderate
nonproliferative
retinopathy

Severe
nonproliferative
retinopathy

Proliferative
retinopathy

_

0.028*

<0.001*

<0.001*

0.030*

No retinopathy

0.028*

_

0.034

0.145

0.855

Mild to moderate
nonproliferative
retinopathy

<0.001*

0.034

_

0.513

0.067

Severe nonproliferative
retinopathy

<0.001*

0.145

0.513

_

0.227

Proliferative retinopathy

0.030*

0.855

0.067

0.227

_

Control

¶ P<0.001 (When comparing the groups together with ANOVA)
* Statistically significant (independent sample t test)

Table 3. CCT of the diabetic patients according to duration of
diabetes.

Table 4. CCT of the diabetic patients according to HbA1c levels.
HbA1c level

Duration of diabetes

CCT (μm)

CCT (μm)
<7%

555.02 ± 32.5

<10 years

561.45 ± 36.4

≥7%

570.61 ± 40.3

≥10 years

565.78 ± 39.0

P value

P value

0.021*

0.522
* Statistically significant (independent sample t test)

is important. If diabetes somewhat causes central
corneal thickening, does CCT correlate with disease
severity? To find the answer, our patients were
classified according to retinopathy status. The results
demonstrated that retinopathy severity had no effect
on CCT. Only patients with mild to moderate
nonproliferative retinopathy had significantly higher
CCT values than the patients with diabetes but with
no retinopathy.
Does glycaemic control have any effect on CCT?
Recently HbA1c level has been emphasised as a
valuable marker of glycaemic control. Haemoglobin
is a protein found in red blood cells. In the
bloodstream, glucose sticks to the red pigment in
haemoglobin forming A1c (HbA1c). Each red blood
cell lives for 8-12 weeks. During this time, the more
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glucose in blood, the more it will stick to the
haemoglobin. HbA1c levels in blood provide
guidance as to what the average blood glucose level
has been for the past 2-3 months. Therefore, regular
HbA1c testing tracks recent glycaemic control. We
investigated HbA1c values and their correlation to
CCT. Patients with higher HbA1c levels (≥7%) had
higher CCT than the patients with lower HbA1c levels
(<7%). In contrast to our results, Larsson et al (6) and
Keoleian et al. (10) did not delineate any correlation
between HbA1c and CCT.
It has been shown that abrupt correction of
hyperglycaemia can result in transient hyperopia.
Research on phakic and aphakic diabetic individuals
indicated that changes in the function and
morphology of the lens were responsible for such
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Table 5. Previous studies on corneal alterations in diabetic patients.

Cohort

Thickness
measurement
method

81 type I diabetics
49 control subjects

Schultz et al.11
(1984)

Study

Central Corneal Thickness (CCT)*

Additional corneal findings

Haag-Streit
pachometer

Central cornea was thicker [544 μm in
nonproliferative, 566 μm in proliferative
retinopathy] than control subjects [527 μm]

Folds in the central endothelial
layer of diabetic eyes.

31 type I diabetic eyes
46 type II diabetic eyes
75 control eyes

Specular
microscope

CCT was similar in both type I [540 μm]
and type II [530-540 μm] diabetics when
compared to controls [540 μm for the
controls of type I diabetics, 530-570 μm
for the controls of type II diabetics]

Increased pleomorphism,
polymegathism, decreased
endothelial cell density in type
I diabetics, increased
pleomorphism, polymegathism,
but no difference in endothelial
cell density in type II diabetics.

Keoleian et al.10
(1992)

14 type I diabetics
14 control subjects

Specular
microscope

CCT [560μm] was similar to control
subjects [560 μm]

Increased pleomorphism,
polymegathism, increased
corneal autofluorescence,
undisturbed endothelial cell
density.

Larsson6
(1996)

49 type I diabetics
60 type II diabetics
40 control subjects

Specular
microscope

CCT was alike in type I [580 μm] and
type II [570 μm] diabetics. Central cornea
was thicker in type I diabetics than controls
[550 μm]. CCT was alike in type II diabetics
and controls [560 μm]

Polymegathism, pleomorphism
and increased corneal
autofluorescence in type I
diabetics. No change in type II
diabetics.

Roszkowska et al.9 30 type I diabetics
(1999)
45 type II diabetics
62 control subjects

Specular
microscope

CCT was higher in both type I [580 μm] and
type II [570 μm] diabetics when compared to
controls [540 μm for type I controls]
[550 μm for type II controls]

Increased pleomorphism,
polymegathism, decreased
endothelial cell density in both
type I and type II diabetics.

Rosenberg et al.3
(2000)

23 type I diabetics
9 control subjects

Confocal
microscope

Patients with severe retinopathy had
significantly higher CCT [596 μm] than
control group [527μm]

Thicker cornea in diabetic
patients without neuropathy.

Lee et al.2
(2006)

200 insulin-dependent
diabetics
100 control subjects

Ultrasound
pachymetry

Diabetics had thicker cornea [588 μm].
Disease duration correlated with CCT

Less corneal cell density,
hexagonality, higher coefficient
of variation in cell size in
diabetes.

Busted et al.
(1981)

8

refractive changes. One would expect that
hyperglycaemia could affect corneal hydration as well
and cause qualitative and quantitative corneal changes
such as change in refractive index, curvature, and
thickness (14,15). Higher HbA1c as a marker of poor
glycaemic control was associated with thicker corneas
in our study. One would also expect that disease
severity and duration would affect corneal thickness

likewise. However, it was not possible to detect any
effect of these factors on corneal thickness. This might
be due to different homeostatic changes taking place
during the chronic course of diabetics. Therefore,
longitudinal follow-up studies need to be performed
in order to ascertain the exact relationship of blood
glucose with the cornea.
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